GILEAD SCIENCES, INC. — Director's Dealing 2014

Nov 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-11-03

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-03	Common Stock	M	3000	$40.56	Acquired	35244	Direct
2014-11-03	Common Stock	S	3000	$112.46	Disposed	32244	Direct
2014-11-04	Common Stock	M	4800	—	Acquired	37044	Direct
2014-11-04	Common Stock	F	2736	$109.72	Acquired	34308	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-03	Non-Qualified Stock Option (right to buy)	$40.56	M	3000	Disposed	2023-02-01	Common Stock (3000)	Direct
2014-11-04	Restricted Stock Unit	$	M	4800	Disposed		Common Stock (4800)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $112.355 to $112.52. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5: The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 25% every year thereafter until fully vested.